谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 267 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
RNA therapeutics for diarrhea
Duy Ha Nguyen, Md Jamal Uddin,Jaffar A Al-Tawfiq,Ziad A Memish,Dinh-Toi Chu
Progress in molecular biology and translational science (2024): 295-309
引用0浏览0WOS引用
0
0
RNA Therapeutics for Regenerative Medicine
Yen Vy Nguyen Thi,Anh Dao Ngo,Dinh-Toi Chu,Sheng-Che Lin,Chia-Ching Wu
Progress in Molecular Biology and Translational Science (2024): 163-176
引用0浏览0WOS引用
0
0
Epigenetic Regulation in Ovarian Cancer
Hue Vu Thi,Anh-Dao Ngo,Dinh-Toi Chu
International review of cell and molecular biology (2024): 77-98
引用0浏览0WOS引用
0
0
Drug repurposing for metabolic disorders: Scientific, technological and economic issues
Nhat-Le Bui, Duc-Anh Hoang, Quang-Anh Ho, Thao-Nguyen Nguyen Thi,Vijai Singh,Dinh-Toi Chu
Progress in molecular biology and translational science (2024): 321-336
引用0浏览0WOS引用
0
0
Drug repurposing for regenerative medicine and cosmetics: Scientific, technological and economic issues
Thuy-Duong Vu, Duc Tri Luong, Thuy-Tien Ho, Thuy-My Nguyen Thi,Vijai Singh,Dinh-Toi Chu
Progress in molecular biology and translational science (2024): 337-353
引用0浏览0WOS引用
0
0
Application of Data Science and Bioinformatics in RNA Therapeutics
Hue Vu Thi, Thanh-Nhat Hoang,Nguyen Quoc Khanh Le,Dinh-Toi Chu
Progress in Molecular Biology and Translational Science (2024): 83-97
引用0浏览0WOS引用
0
0
RNA Therapeutics for Respiratory Diseases
Hue Vu Thi, Linh Thao Tran,Huy Quang Nguyen,Dinh-Toi Chu
Progress in molecular biology and translational science (2024)
引用0浏览0WOS引用
0
0
Biosafety and Regulatory Issues of RNA Therapeutics
Hue Vu Thi, Lan-Anh Nguyen Thi, Thuy Linh Tang,Dinh-Toi Chu
Progress in Molecular Biology and Translational Science (2024): 311-329
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 284

#Citation: 17387

H-Index: 54

G-Index: 131

Sociability: 9

Diversity: 3

Activity: 110

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn